View in EDS

Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia.
Authors: Jiménez-Vicente C; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona., Arribas I; Hematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona., Pomares H; Hematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona., Ramil G; Department of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant Pau., Castaño-Diez S; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona., Pérez-Valencia AI; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona., Sturla AL; Hematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona., López-Guerra M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hemopathology Unit, Pathology Department. Hospital Clinic de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid., Martinez-Roca A; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona., Zugasti I; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona., Guijarro F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hemopathology Unit, Pathology Department. Hospital Clinic de Barcelona, Barcelona., Cortés-Bullich A; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona., Merchán B; Hematology Department. Hospital Clínic de Barcelona, Barcelona., Triguero A; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona., Monge I; Pharmacy Department, Hospital Clínic de Barcelona., Tuca A; Medical Oncology Department, Hospital Clinic de Barcelona., Oñate G; Department of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant Pau., Garrido A; Department of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant Pau., Sierra J; Department of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant Pau., Arnan M; Hematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona., Esteve J; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona, Spain; Josep Carreras Leukemia Research Institute, Barcelona., Díaz-Beyá M; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona, Spain; Josep Carreras Leukemia Research Institute, Barcelona. diazbeya@clinic.cat., Group SC; .
Source: Haematologica [Haematologica] 2025 Jun 01; Vol. 110 (6), pp. 1402-1406. Date of Electronic Publication: 2025 Jan 23.
Publication Type: Journal Article
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39844754
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jiménez-Vicente+C%22">Jiménez-Vicente C</searchLink>; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona.<br /><searchLink fieldCode="AU" term="%22Arribas+I%22">Arribas I</searchLink>; Hematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona.<br /><searchLink fieldCode="AU" term="%22Pomares+H%22">Pomares H</searchLink>; Hematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona.<br /><searchLink fieldCode="AU" term="%22Ramil+G%22">Ramil G</searchLink>; Department of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant Pau.<br /><searchLink fieldCode="AU" term="%22Castaño-Diez+S%22">Castaño-Diez S</searchLink>; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona.<br /><searchLink fieldCode="AU" term="%22Pérez-Valencia+AI%22">Pérez-Valencia AI</searchLink>; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona.<br /><searchLink fieldCode="AU" term="%22Sturla+AL%22">Sturla AL</searchLink>; Hematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona.<br /><searchLink fieldCode="AU" term="%22López-Guerra+M%22">López-Guerra M</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hemopathology Unit, Pathology Department. Hospital Clinic de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid.<br /><searchLink fieldCode="AU" term="%22Martinez-Roca+A%22">Martinez-Roca A</searchLink>; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona.<br /><searchLink fieldCode="AU" term="%22Zugasti+I%22">Zugasti I</searchLink>; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona.<br /><searchLink fieldCode="AU" term="%22Guijarro+F%22">Guijarro F</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hemopathology Unit, Pathology Department. Hospital Clinic de Barcelona, Barcelona.<br /><searchLink fieldCode="AU" term="%22Cortés-Bullich+A%22">Cortés-Bullich A</searchLink>; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona.<br /><searchLink fieldCode="AU" term="%22Merchán+B%22">Merchán B</searchLink>; Hematology Department. Hospital Clínic de Barcelona, Barcelona.<br /><searchLink fieldCode="AU" term="%22Triguero+A%22">Triguero A</searchLink>; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona.<br /><searchLink fieldCode="AU" term="%22Monge+I%22">Monge I</searchLink>; Pharmacy Department, Hospital Clínic de Barcelona.<br /><searchLink fieldCode="AU" term="%22Tuca+A%22">Tuca A</searchLink>; Medical Oncology Department, Hospital Clinic de Barcelona.<br /><searchLink fieldCode="AU" term="%22Oñate+G%22">Oñate G</searchLink>; Department of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant Pau.<br /><searchLink fieldCode="AU" term="%22Garrido+A%22">Garrido A</searchLink>; Department of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant Pau.<br /><searchLink fieldCode="AU" term="%22Sierra+J%22">Sierra J</searchLink>; Department of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant Pau.<br /><searchLink fieldCode="AU" term="%22Arnan+M%22">Arnan M</searchLink>; Hematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona.<br /><searchLink fieldCode="AU" term="%22Esteve+J%22">Esteve J</searchLink>; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona, Spain; Josep Carreras Leukemia Research Institute, Barcelona.<br /><searchLink fieldCode="AU" term="%22Díaz-Beyá+M%22">Díaz-Beyá M</searchLink>; Hematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona, Spain; Josep Carreras Leukemia Research Institute, Barcelona. diazbeya@clinic.cat.<br /><searchLink fieldCode="AU" term="%22Group+SC%22">Group SC</searchLink>; .
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2025 Jun 01; Vol. 110 (6), pp. 1402-1406. <i>Date of Electronic Publication: </i>2025 Jan 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39844754
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3324/haematol.2024.286589
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1402
    Titles:
      – TitleFull: Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jiménez-Vicente C
      – PersonEntity:
          Name:
            NameFull: Arribas I
      – PersonEntity:
          Name:
            NameFull: Pomares H
      – PersonEntity:
          Name:
            NameFull: Ramil G
      – PersonEntity:
          Name:
            NameFull: Castaño-Diez S
      – PersonEntity:
          Name:
            NameFull: Pérez-Valencia AI
      – PersonEntity:
          Name:
            NameFull: Sturla AL
      – PersonEntity:
          Name:
            NameFull: López-Guerra M
      – PersonEntity:
          Name:
            NameFull: Martinez-Roca A
      – PersonEntity:
          Name:
            NameFull: Zugasti I
      – PersonEntity:
          Name:
            NameFull: Guijarro F
      – PersonEntity:
          Name:
            NameFull: Cortés-Bullich A
      – PersonEntity:
          Name:
            NameFull: Merchán B
      – PersonEntity:
          Name:
            NameFull: Triguero A
      – PersonEntity:
          Name:
            NameFull: Monge I
      – PersonEntity:
          Name:
            NameFull: Tuca A
      – PersonEntity:
          Name:
            NameFull: Oñate G
      – PersonEntity:
          Name:
            NameFull: Garrido A
      – PersonEntity:
          Name:
            NameFull: Sierra J
      – PersonEntity:
          Name:
            NameFull: Arnan M
      – PersonEntity:
          Name:
            NameFull: Esteve J
      – PersonEntity:
          Name:
            NameFull: Díaz-Beyá M
      – PersonEntity:
          Name:
            NameFull: Group SC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1592-8721
          Numbering:
            – Type: volume
              Value: 110
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Haematologica
              Type: main
ResultId 1